As part of a promising partnership, CEPID CancerThera welcomed on May 21 a team of representatives from Amazônia Azul Tecnologias de Defesa S.A. (Amazul), a company that plays a crucial role in the Brazilian Nuclear Program (PNB), the Navy’s Nuclear Program (PNM), and the Submarine Development Program (Prosub).

The meeting marked progress in the development of the new Preclinical Research Laboratory project at Unicamp, which will be dedicated to studies in the areas of Radiochemistry, Molecular Biology, and Cell Culture. The meeting was attended by engineers and architects from Amazul, as well as researchers from CancerThera. During the meeting, procedures for the development of the laboratory project were discussed.

The Amazul team had the opportunity to visit the Integrated Center for Onco-hematological Research in Childhood (Cipoi), part of the Faculty of Medical Sciences (FCM) at Unicamp, where the area designated for the Radiochemistry laboratory was presented. The infrastructure will be designed with the collaboration of several departments at Unicamp, including FCM, the Clinical Hospital (HC), the “Gleb Wataghin” Institute of Physics (IFGW), and other university departments.

The Amazul representatives showed great interest and commitment to the project, which will be developed in compliance with the standards of the National Nuclear Energy Commission (CNEN) and the National Health Surveillance Agency (Anvisa). In the coming months, the Amazul team will conduct interviews with each researcher who will use the laboratory to better understand their specific needs in terms of equipment and infrastructure.

The collaboration between CancerThera and Amazul promises to bring significant advances in scientific research, benefiting not only the nuclear programs but also contributing to science and technology in Brazil. “The expectation is that this will be the first step in a long-term partnership between Unicamp and Amazul, with plans to expand the work to other areas and institutes of the university in the future,” highlights Prof. Dr. Celso Darío Ramos, nuclear medicine physician, principal investigator, and vice-director of the CancerThera executive committee. Recently, Ramos was appointed as a member of Amazul’s scientific committee, further strengthening the ties between the institution and the research center.

Meeting participants

From CancerThera (Unicamp):
Prof. Dr. Carmen Silvia Passos Lima (FCM/Unicamp)
Prof. Dr. Carmino Antonio de Souza (FCM/Unicamp)
Prof. Dr. Celso Dario Ramos (FCM-Unicamp)
Prof. Dr. Daniel Massaro Onusic (CEB/Unicamp)
Dr. Juliana Carron (FCM/Unicamp)
Prof. Dr. Luciana Malavolta Quaglio (FCM/Santa Casa de São Paulo)
Prof. Dr. Gilberto Carlos Franchi Jr. (Cipoi/Unicamp)
Prof. Dr. Vânia Pereira de Castro Rodrigues (Radiopharmacy/HC/Unicamp)
Prof. Dr. Victor Marcelo Deflon (IQSC/USP)

From Amazul:
Afonso Palmieri Ferreira Correia
Ana Cristina dos Santos Bastos
Cláudio Monteiro Pires
Eros Duarte Ortigoso Carbi
Flávio Malerman
Flávio Soares Pereira
Luciani Aparecida Ferreira
Maria Cristina Ibelli

_{Text: Romulo Santana Osthues}_{| Photos: Carmen S. P. Lima}